The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Advertisement
The Scientist
Most Recent
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
New research adds to an emerging picture of the changes that global warming and thinning ice are wreaking on the marine ecosystems at the top of the world.
Scenes from a research trip, where researchers peered beneath the ice to shine a light on the emerging picture of a changing Arctic Ocean
In a pond, more amphibian species mean decreased chances of disease spread.
A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.
Scientists have identified the sticky substance that is damaging the feathers of hundreds seabirds washed ashore in England as an additive for lubricant oils.
New amphibian species are being discovered at an exciting rate, yet they are also the vertebrates most at risk of extinction.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
Watch as the astounding wood frog uses cellular cryopreservation tricks to freeze, thaw, and live to croak about it.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
